Skip to content

Clinical trials

Suspended Myelodysplastic Syndromes trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Status: Suspended Country / region: United States Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20181
20202
20212
20221
20242
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Suspended14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
City of Hope Medical Center4
Abhay Singh, MD MPH1
Curis, Inc.1
Cyclacel Pharmaceuticals, Inc.1
David Wald1
Fred Hutchinson Cancer Center1
Humanigen, Inc.1
Leland Metheny1
Mikkael Sekeres, MD1
National Cancer Institute (NCI)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes14
Leukemia, Myeloid, Acute8
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Hodgkin Disease2
Leukemia2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive2
Leukemia, Myelomonocytic, Chronic2
Colorectal Neoplasms1
Esophageal Neoplasms1
GATA2 Deficiency1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.